Higher prevalence of thrombophilia in patients with varicose veins and venous ulcers than controls

Bradbury, 2002, Thrombophilia and chronic venous ulceration, Eur J Vasc Endovasc Surg, 24, 97, 10.1053/ejvs.2002.1683 MacKenzie, 2002, The prevalence of thrombophilia in patients with chronic venous leg ulceration, J Vasc Surg, 35, 718, 10.1067/mva.2002.121749 Sam, 2003, The prevalence of hyperhomocysteinaemia, methylene tetrahydrofolate reductase C677T mutation, and vitamin B12 and folate deficiency in patients with chronic venous insufficiency, J Vasc Surg, 38, 904, 10.1016/S0741-5214(03)00923-6 Gaber, 2001, Resistance to activated protein C due to factor V Leiden mutation: high prevalence in patients with post-thrombotic leg ulcers, Br J Dermatol, 144, 546, 10.1046/j.1365-2133.2001.04081.x Grossman, 1997, Activated protein C resistance and anticardiolipin antibodies in patients with venous leg ulcers, J Am Acad Dermatol, 37, 409, 10.1016/S0190-9622(97)70141-5 Pereira de Godoy, 2001, Prevalence of antithrombin deficiency in patients with chronic leg ulcer, Blood Coagulation and Fibrinolysis, 12, 593, 10.1097/00001721-200110000-00013 Yasim, 2008, Serum concentration of procoagulant, endothelial and oxidative stress markers in early primary varicose veins, Phlebology, 23, 15, 10.1258/phleb.2007.007014 Eklof, 2004, American Venous Forum International Ad Hoc Committee for the Revision of the CEAP Classification, J Vasc Surg, 40, 1248 Poort, 1996, A common genetic variation in the 3°Ç-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis, Blood, 88, 3698, 10.1182/blood.V88.10.3698.bloodjournal88103698 Gandrille, 1995, A rapid screening method for the factor V arg506-gln mutation, Blood Coagulation and Fibrinolysis, 6, 245, 10.1097/00001721-199505000-00008 Murin, 1998, Hereditary thrombophilia and venous thromboembolism, Am J Respir Crit Care Med, 158, 1369, 10.1164/ajrccm.158.5.9712022 Munkvad, 1996, Resistance to activated protein C: a common anticoagulant deficiency in patients with venous leg ulceration, Br J Dermatol, 134, 296, 10.1111/j.1365-2133.1996.tb07617.x Hafner, 1997, Resistance to activated protein C in patients with venous leg ulcers, Dermatology, 195, 413, 10.1159/000246006 Maessen-Visch, 1999, The prevalence of factor V Leiden mutation in patients with leg ulcers and venous insufficiency, Arch Dermatol, 135, 41, 10.1001/archderm.135.1.41 Ribeaudeau, 1999, A prospective coagulation study including resistance to activated protein C and mutations in factors V and II in venous leg ulcers, Br J Dermat, 141, 259, 10.1046/j.1365-2133.1999.03026.x Rosendaal, 1999, Venous thrombosis: a multicausal disease, Lancet, 353, 1167, 10.1016/S0140-6736(98)10266-0 Alcaraz, 1999, Leg ulcers and antiphospholipid antibodies, Ann Dermatol Venereol, 126, 313 Fink, 2002, Lupus anticoagulant and venous leg ulceration, Br J Dermatol, 146, 308, 10.1046/j.0007-0963.2001.04546.x Tait, 1995, Prevalence of protein C deficiency in the healthy population, Thromb Haemost, 73, 87, 10.1055/s-0038-1653730 Falanga, 1990, Protein C and protein S plasma levels in patients with lipodermatosclerosis and venous ulceration, Arch Dermatol, 126, 1195, 10.1001/archderm.1990.01670330075010 Herrmann, 2001, The importance of hyperhomocysteinaemia as a risk factor for disease: an overview, Clin Chem Lab Med, 39, 666, 10.1515/CCLM.2001.110 Simioni, 1996, Hyperhomocysteinaemia and deep-vein thrombosis: a case-control study, Thromb Haemost, 76, 883, 10.1055/s-0038-1650680 den Heijer, 1998, Hyperhomocysteinaemia and venous thrombosis: a meta-analysis, Thromb Haemost, 80, 874, 10.1055/s-0037-1615380 Ray, 1998, Meta-analysis of hyperhomocysteinaemia as a risk factor for venous thromboembolic disease, Arch Int Med, 158, 2101, 10.1001/archinte.158.19.2101 Key, 2002, Hyperhomocysteinaemia and thrombophilia, Arch Pathol Lab Med, 126, 1367, 10.5858/2002-126-1367-HAT Ibbotson, 1995, The effect of aspirin on haemostatic activity in the treatment of chronic venous ulceration, Br J Dermatol, 132, 422, 10.1111/j.1365-2133.1995.tb08676.x Koster, 1995, Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis, Lancet, 345, 152, 10.1016/S0140-6736(95)90166-3 Kamphuisen, 2001, Elevated factor VIII levels and the risk of thrombosis, Arterioscler Thromb Vasc Biol, 21, 731, 10.1161/01.ATV.21.5.731 Sam, 2005, The association between raised coagulation factor levels and venous thrombo-embolism, Eur J Vasc Endovasc Surg, 30, 539, 10.1016/j.ejvs.2004.11.017 Kyrle, 2000, High plasma levels of factor VIII and the risk of recurrent venous thrombo-embolism, N Engl J Med, 343, 457, 10.1056/NEJM200008173430702 Cristina, 2004, High plasma levels of factor VIII and risk of recurrence of venous thromboembolism, Br J Haematol, 124, 504, 10.1046/j.1365-2141.2003.04795.x Lowe, 1997, Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey, Br J Haematol, 97, 775, 10.1046/j.1365-2141.1997.1222936.x Lowe, 1999, Activated protein C resistance and the FV:R506Q mutation in a random population sample–associations with cardiovascular risk factors and coagulation variables, Thromb Haemost, 81, 918, 10.1055/s-0037-1614599 O'Donnell, 2001, Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism, Br J Haematol, 115, 687, 10.1046/j.1365-2141.2001.03146.x Lowe, 2001, Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein–a cross-sectional population survey, Thromb Haemost, 86, 550, 10.1055/s-0037-1616085 Van Hylckama Vlieg, 2000, High levels of factor IX increase the risk of venous thrombosis, Blood, 95, 3678, 10.1182/blood.V95.12.3678 Meijers, 2000, High levels of coagulation factor XI as a risk factor for venous thrombosis, N Engl J Med, 342, 696, 10.1056/NEJM200003093421004 Kolbach, 2002, Recurrent leg ulcers in a young man with hyperhomocysteinemia, factor V Leiden and impaired fibrinolysis, Acta Derm Venereol, 82, 52, 10.1080/000155502753600902 Brandt, 2007, Leg ulcers associated with factor V Leiden and prothrombin G20210A and methyltetrahydrofolate reductase mutations: successful treatment with warfarin, Int J Dermatol, 46, 1319, 10.1111/j.1365-4632.2007.03424.x Bick, 2001, Stasis ulcers refractory to therapy–accelerated healing by treatment with clopidogrel +/− dalteparin: a preliminary report, Clin Appl Thromb Hemost, 7, 21, 10.1177/107602960100700105